Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Nanogate successfully closes transaction and capital increase for equity investment in sarastro GmbH

Abstract:
A capital increase in kind is to finance the equity investment in sarastro, previously a cooperation partner

Nanogate successfully closes transaction and capital increase for equity investment in sarastro GmbH

Göttelborn, Germany | Posted on April 29th, 2010

Nanogate (ISIN DE000A0JKHC9), a leading international nanotechnology enabler, has formally completed the capital increase as announced. The 5,000 new shares have now been entered in the commercial register, taking the total number of shares in Nanogate AG to 1,905,000. In December 2009 Nanogate had announced its intention to acquire a 25.1 % stake and an option for the majority of shares in sarastro GmbH. The purchase price is a low six-figure euro amount and consists of cash and share components. With this investment Nanogate has added biocompatible solutions to its technology portfolio. The nanotechnology company sarastro specialises in producing antimicrobial and medically tolerable surfaces. The first joint product is now available commercially.

Nanogate and sarastro together intend to equip materials, surfaces and products for a wide variety of applications with new biological properties, creating high-performance solutions for a rapidly growing market. The first joint project is the technology platform permaProtect Membran, which for the first time combines antimicrobial, breathable and moisture-controlling properties in one membrane. This new technology is the basis for an order received by Nanogate to manufacture initial products that offer improved hygienic properties and greater comfort. It comes from a leading European shoe retailer.

In 2009 sarastro reported a high six-figure euro sum in sales and achieved break-even. sarastro's technology is used for instance in hearing aids from Siemens and a leading Swiss manufacturer, as well as in filtration systems for drinking water purification and in PVC air and water hoses. The company also produces disinfectants and other fluids with a patented technology that enables an especially long-lasting disinfectant and antimicrobial action.

Disclaimer:

This publication constitutes neither an offer to sell nor an invitation to buy securities. The shares in Nanogate AG (the "Shares") may not be offered or sold in the United States or to or for the account or benefit of "U.S. persons" (as such term is defined in Regulation S under the U.S. Securities Act of 1933, as amended (the "Securities Act")). No offer or sale of transferable securities is being made to the public outside Germany.

####

About Nanogate AG
Nanogate is a leading international enabler in the nanotechnology growth market and so opens the gate to this technology for its customers. The firm, which is based in Göttelborn (Saarland), enables the programming and integration of additional properties – such as non-stick, anti-bacterial, anti-corrosive and ultra-low friction – into materials and surfaces. Nanogate thereby gains a competitive edge for its customers by product refinement using chemical nanotechnology. Nanogate covers a wide range of industries, functions and substrates on the basis of technology platforms. The company thus provides a decisive interface for the commercial use of chemical nanotechnology and bridges the gap between the suppliers of raw materials and industrial conversion into products. In doing so, Nanogate concentrates as an enabler on one of the most attractive segments in the industry. As a partner in innovation, Nanogate provides many services along the value chain – from development and production of innovative nanocomposities and nanostructured materials to powerful support for innovation and product integration.

The Nanogate Group currently has 82 employees in all (as of April 2010) and since commencing operations in 1999 has been a trailblazer in nanotechnology. The company has first-class customer references (e.g. ABB, BSH Bosch-Siemens Haushaltsgeräte, Kärcher, Koenig & Bauer AG, Opel and REWE Austria) and many years’ experience of different industries and applications. To date, more than 180 projects have gone into mass production. Nanogate has also entered into strategic cooperations with international companies such as the GEA Group and Dow Corning. The Group also includes Nanogate Advanced Materials GmbH, which specialises in complex applications like high-performance optics, FNP GmbH in the area of sport/leisure, a majority shareholding in Holmenkol AG and a shareholding in sarastro GmbH.

Innovation-driven competitive advantage

Using this guiding motto, Nanogate AG launched a comprehensive innovation offensive in 2009 in order to open up new growth prospects for its clients. To achieve this, Nanogate increased its investments and funding significantly - in particular in the 2009 financial year - and has since then presented a multitude of innovations. Since going public in 2006 the company has already invested several million euros in developing new technology platforms and has transformed these into marketable products. Nanogate has successfully illustrated its expertise in more than 180 cases, using innovations to provide its clients with a competitive advantage.

About sarastro GmbH

The nanotech company sarastro GmbH specialises in developing and marketing biologically active functional surface finishes. Established in 2001, sarastro offers innovative solutions based on chemical nanotechnology for applications from the fields of medicine, medical technology, life science, hygiene, cosmetics and food. The company’s customers include Wincor-Nixdorf and Siemens. The firm currently has twelve employees, most of whom are scientists (chemists, biologists and doctors).

The company’s own chemical and biological laboratories are crucial to successfully developing and marketing new solutions. They enable sarastro to check that newly developed materials comply both with standard technical requirements and with biological and medical compatibility specifications. Quality-controlled production is guaranteed by a quality management system in accordance with DIN EN ISO 13485:2007 and Annex V 93/42/EEC. As well as guaranteeing top-quality development, sarastro thus ensures that newly developed materials are produced to the high standard expected in the industry.

For more information, please click here

Contacts:
Christian Dose (financial press and investors)
Cortent Kommunikation AG
Tel. +49 (0)69 5770 300-0


Karen Kumposcht (business and trade press)
MPW FINANCE Public & Investor Relations GmbH
Tel. +49 (0)69 9592 90-12


Nanogate AG
Zum Schacht 3
66287 Göttelborn
Germany



Copyright © Nanogate AG

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Nano Ruffles in Brain Matter: Freiburg researchers decipher the role of nanostructures around brain cells in central nervous system function October 31st, 2014

Gold nanoparticle chains confine light to the nanoscale October 31st, 2014

'Nanomotor lithography' answers call for affordable, simpler device manufacturing October 31st, 2014

Device invented at Johns Hopkins provides up-close look at cancer on the move: Microscopic view of metastasis could give insight about how to keep cancer in check October 31st, 2014

Investments/IPO's/Splits

TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014

Arrowhead Issues Open Letter to Shareholders October 9th, 2014

PEN Inc. Announces New Trading Symbol: PENC: Stock Continues Trading on the OTCQB September 3rd, 2014

Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014

Nanomedicine

Nano Ruffles in Brain Matter: Freiburg researchers decipher the role of nanostructures around brain cells in central nervous system function October 31st, 2014

Production of Biocompatible Polymers in Iran October 30th, 2014

Amorphous Coordination Polymer Particles as alternative to classical nanoplatforms for nanomedicine October 30th, 2014

'Electronic skin' could improve early breast cancer detection October 29th, 2014

Announcements

Nano Ruffles in Brain Matter: Freiburg researchers decipher the role of nanostructures around brain cells in central nervous system function October 31st, 2014

Gold nanoparticle chains confine light to the nanoscale October 31st, 2014

'Nanomotor lithography' answers call for affordable, simpler device manufacturing October 31st, 2014

Device invented at Johns Hopkins provides up-close look at cancer on the move: Microscopic view of metastasis could give insight about how to keep cancer in check October 31st, 2014

Alliances/Partnerships/Distributorships

'Electronic skin' could improve early breast cancer detection October 29th, 2014

European Commission opens the gate towards the implementation of Nanomedicine Translation Hub October 16th, 2014

IRLYNX and CEA-Leti to Streamline New CMOS-based Infrared Sensing Modules Dedicated to Human-activities Characterization October 15th, 2014

New VDMA Association "Electronics, Micro and Nano Technologies" founded: Inaugural Meeting in Frankfurt/Main, Germany October 15th, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE